StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Royalty Pharma plc
NasdaqGS:RPRX
Sector
Location
Market Cap
USD 20.35 B
Share Price
USD 36.19
Avg Daily Volume
4,950,160
Change (1 day)
0.86%
Change (1 year)
39.84%
Change (YTD)
41.87%
Royalty Pharma plc Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 99.66%
Royalty Pharma plc Gross Profit Margin is 99.66% for the Trailing 12 Months (TTM) ending March 31, 2025, a 110.46% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Royalty Pharma plc Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 47.35%, a -38.75% change year over year.
-
Royalty Pharma plc Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 77.31%, a -11.69% change year over year.
-
Royalty Pharma plc Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 87.55%, a -6.19% change year over year.
-
Royalty Pharma plc Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 93.32%, a 158.60% change year over year.
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Key Data
| Date | Gross Profit Margin | EBIT Margin | EBITDA Margin | Net Income Margin |
|---|
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%